FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $11.59 million.
GUIDANCE:
Aquestive Therapeutics Inc. sees FY2019 revenue of $33-45 million,... More

